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SHORT AND LONG-TERM EFFECT OF CHONDROCYTE VERSUS
MESENCHYMAL STEM CELLS GROWN ONTO A HYALURONAN-
BASED SCAFFOLD IN IN A RABBIT OSTEOARTHRITIS MODEL
G. Desando, Jr., C. Cavallo, Jr., I. Bartolotti, Jr., M. Tschon, Sr.,
G. Giavaresi, Sr., L. Martini, Sr., M. Fini, Sr., B. Grigolo, Sr.. Istituto
Ortopedico Rizzoli, Bologna, Italy
Purpose: Osteoarthritis (OA) is a major health issue worldwide due to
the increasing age of active population and the impact on patients' daily
life. Cartilage and synovial alterations are important factors involved in
OA progression. Despite the advancements in this ﬁeld, there is a largely
unmet medical need for durable disease-modifying treatments. Cell-
based therapies have become thriving therapeutic options for OA but
nevertheless the choice of the suitable cell candidate is a source of
debate. The purpose of this work was aimed to compare the regener-
ative potential of chondrocytes versus Mesenchymal Stem Cells (MSC),
grown onto a hyaluronan-based scaffold (Hyaff-11) in counteracting OA
progression in an experimental OA rabbit model at short and long-term
follow-ups.
Methods: Adult male New Zealand rabbits were enrolled in this study
according to European and Italian laws for animal experimentation. A
mild grade of OA was induced surgically through bilateral Anterior
Cruciate Ligament Transection at 8 weeks. Chondrocytes and MSC were
isolated from rabbit articular cartilage and bone marrow respectively,
grown in monolayer cultures, seeded onto Hyaff-11 (HA) and trans-
planted after OA onset. Animals were divided into two groups: 1)
chondrocyte-seeded HA (Chondro-HA) and 2) MSC-seeded HA (MSC-
HA). Empty HAwas used as control. Animals were euthanized at 3 and 6
months. Cartilage and synovia were assessed by histology supported by
modiﬁed Mankin score and histomorphometric analyses. Protein
expression of collagen type I, II and X, MMP-1, MMP-3 and MMP-13
were assessed by immunohistochemistry. The General Linear Model
with Sidak correction was used to compare the two cell-based
therapies.
Results: At 3 months, chondro-HA group displayed an active con-
tribution in reducing OA changes especially on cartilage with an
improvement of tissue morphology, extracellular matrix organization
and cell distribution compared to MSC-HA-one (p<0.05); the effects on
synovia were less pronounced. Further analyses conﬁrmed these ﬁnd-
ings with a decrease of MMP-3, MMP-13 and TNF-a mainly in cartilage
(p<0.05). A reduction of hypertrophic processes was evident in cartilage
for both cell treatments compared to HA (p<0.05). At 6 months, MSC-
HA therapy displayed the best macroscopic and histological ﬁndings on
cartilage and synovial tissues than chondro-HA-one (p<0.05). This last
displayed some endochondral ossiﬁcation processes and thickening of
the subchondral bone plate in femur and hyperplasia and ﬁbrous
reactions in synovia. Moreover, a decreased presence of MMP-1, -3, -13,
TNF-a and some hypertrophic markers was evident for MSC-HA therapy
at both tissue level. Conversely, an increase of collagen X and alkaline
phosphatase was noticed for chondro-HA therapy at long-term follow-up. In general, various degrees of tissue remodeling were noticed with
HA treatment.
Conclusions: Our ﬁndings revealed a positive effect of chondro-HA and
MSC-HA therapies in promoting cartilage healing and counteracting
some OA inﬂammatory and degenerative processes. However, the efﬁ-
cacy of chondro-HA therapy was focused mainly on cartilage tissue and
was time-dependent probably due to: 1) chondrocyte changes towards
a ﬁbrous and hypertrophic phenotype during the time; and 2) low
effectiveness on synovia. On the other hand, MSC-HA treatment had a
wider spectrum of action than chondro-HA, exerting its healing
potential not only on cartilage tissue but also on synovia. Thus, the use
of chondrocytes could be suggested in the early stage of OA when a
precocious action is mandatory; whereas the use of MSC could be more
appropriate at both early and moderate stages of OA, since they would
seem to guarantee a more stable repair during the time.
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CHARACTERISATION OF ENGRAFTED MESENCHYMAL STEM CELLS
POST INTRA-ARTICULAR INJECTION IN HEALTHY MOUSE JOINT
P. Mancuso y, S. Hanley z, G. Shaw y, C. O'Flatharta y, M. Murphy y,
F. Barry y. yREMEDI (NUI), Galway, Ireland; z Flow Cytometry Core Facility,
NCBES (NUI), Galway, Ireland
Purpose: Due to its avascular nature and low chondrocyte proliferation,
cartilage has little self-repair capacity. As such, injuries to the articular
surface may lead to sustained degeneration as in osteoarthritis (OA).
Mesenchymal stem cells (MSCs) are considered a promising tool for the
repair of damaged cartilage, due to their chondrogenic differentiation
potential or secretory proﬁle, and have been shown to engraft and
promote regeneration when locally administered. The aim of this study
was to assess the inﬂuence of the articular microenvironment on the
viability and differentiation potential of locally delivered MSCs, in order
to study the molecular mechanisms of repair in a murine model of OA.
Methods: GFP-expressing MSCs were isolated from C57BL/6-Tg(UBC-
GFP)30Scha/J mice and expanded in culture. After 5-6 passages, a single
dose of 2105 cells suspended in Minimum Essential Medium (MEM)-
alpha was intra-articularly delivered into healthy 8-week-old C57BL/6
mice. Control animals received MEM-a only. After three days, knee
joints were either decalciﬁed and processed for histology or digested in
a solution of 2 mg/ml Collagenase type I to obtain a single cell sus-
pension. Cell suspensions from 4 knee joints were pooled and sorted
based on ﬂuorescence intensity using the BD FACS Aria II. GFPþ MSCs,
pre- and post-intra-articular (post-IA) injection, underwent CFU-F assay
and osteogenic/chondrogenic/adipogenic potential evaluation through
culturing in differentiative media.
Results: 1.63% of the injected cells were successfully retrieved by cell
sorting, with 82.1% sample purity. Histological analysis showed
engraftment of single cells, particularly after three days, at the level of
articular cartilage and synovial membrane (Fig.1), as well as attachment
to ligament. The sorted cells were able to grow in culture, retaining
ﬂuorescence and a spindle-shaped morphology (Fig. 2). Post-IA MSCs
showed a slightly higher growth potential and a more than doubled
clonogenic potential. Post-IA MSCs only formed immature adipocytes
with limited fat content and no fully formed droplets, but semi-quan-
tiﬁcation did not show any loss in adipogenic differentiation potential.
Post-IA cells also showed a slight but not signiﬁcant decrease in
osteogenic potential and post-IA chondrogenic pellets exhibited less
extensive Safranin-O staining, indicating a lower production of pro-
teoglycan (GAG) in the extracellular matrix. However, assessment of the
GAG/DNA ratio indicated an increase in chondrogenic differentiation
after exposure to the synovial environment.
Conclusions: It was shown that MSCs can be administered, tracked and
retrieved from murine knee joints. Observed ﬂuorescence originates
from injected cells and is not the result of phagocytosis from the host
immune system. After exposure to the synovial environment, syngeneic
cells are not only able to integrate in the tissue but also retain a similar
behavior to MSCs in culture. In particular, the increased clonogenic
potential suggests that the synovial environment selects a narrower
population of quiescent progenitor cells. IA-injected cells, while main-
taining the capacity for forming osteocytes and adipocytes showed
increased chondrogenic capacity. This suggests a potential beneﬁt for
degenerative conditions that affect articular cartilage. These results,
obtained in healthy animals, will serve as a proof-of-principle to study
the changes that MSCs undergo in the synovial microenvironment of a
murine model of OA.
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ENHANCED CHONDROGENIC DIFFERENTIATION OF HUMAN
OSTEOARTHRITIC BONE MARROW ASPIRATES MODIFIED TO
OVEREXPRESS THE TRANSCRIPTION FACTOR SOX9 VIA RAAV-
MEDIATED GENE TRANSFER IN DYNAMIC VERSUS STATIC CULTURE
CONDITIONS
J.K. Venkatesan, A. Rey-Rico, J. Frisch, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: Administration of bone marrow aspirates modiﬁed to over-
express reparative genes is a promising approach to remodel damaged
articular cartilage. The goal of this study was to test whether gene
transfer of the chondrogenic SOX9 transcription factor in human
osteoarthritic bone marrow aspirates via the potent, clinically relevant
rAAV vector stimulates the chondrogenic differentiation processes
under mechanical loading culture conditions.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-FLAG-hsox9 versus control (reporter) rAAV-luc (Fireﬂy
luciferase) constructs. Aspirates were transduced with each vector and
placed in mixed ﬁbrinogen/thrombin for over time (21 days) main-
tenance in dynamic ﬂow rotating bioreactors versus static culture
conditions using chondrogenic medium. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with safranin O and for immuno-
detection of type-II, type-I, and type-X collagen. The DNA, proteoglycan,
and type-II collagen contents were monitored by Hoechst 22358 assay,
binding to DMMB, and ELISA, respectively. Total RNAwas extracted and
reverse transcription was carried out for cDNA ampliﬁcation via real-
time RT-PCR. Ct values were obtained for SOX9, COL2A1, COL1A1, and
COL10A1, using GAPDH as a control for normalization, and fold induc-
tions relative to luc-treated samples were measured using the 2-DDCt
method. Each condition was performed in triplicate in three experi-
ments. The t-test was employed with P  0.05 considered statistically
signiﬁcant.
Results: Effective sox9 expression was observed in rAAV-FLAG-hsox9-
versus rAAV-luc-treated aspirates both in dynamic and static con-
ditions. Successful chondrogenic differentiation in the aspirates was
observed after 21 days in both types of culture by safranin O staining
and immunodetection of type-II collagen while immunoreactivity to
type-I and -X collagen was less intense when applying rAAV sox9. The
candidate sox9 treatment signiﬁcantly increased the DNA contents in
static culture versus luc but no effects were noted upon the proteo-
glycan and type-II collagen contents. In contrast, application of sox9
increased both the DNA, proteoglycan, and type-II collagen contents in
dynamic culture versus luc, with effects that were more marked than instatic condition. All ﬁndings were corroborated at the gene expression
level via real-time RT-PCR analysis.
Conclusions: Human osteoarthritic bone marrow aspirates can be
modiﬁed via rAAV to overexpress SOX9, leading to enhanced chon-
drogenesis in dynamic culture conditions, showing the value of such an
approach for the future development of novel treatments to repair
damaged articular cartilage.
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EFFECTS OF IGF-I OVEREXPRESSION ON THE CHONDROGENIC
POTENTIAL OF HUMAN BONE MARROW ASPIRATES MODIFIED VIA
RAAV GENE TRANSFER
J. Frisch, A. Rey-Rico, J.K. Venkatesan, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: The use of genetically modiﬁed bone marrow aspirates may
provide convenient, one-step therapeutic approaches to regenerate
injured articular cartilage. Here, we examined the effects of over-
expressing the mitogenic and pro-anabolic IGF-I factor via the potent
and safe rAAV gene transfer vectors on the reparative activities of
human osteoarthritic bone marrow aspirates.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-hIGF-I versus control (reporter) rAAV-lacZ constructs.
Aspirates were transduced with each vector and maintained in chon-
drogenic culture condition for 21 days. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with toluidine blue and for immu-
nodetection of type-II collagen. The DNA and proteoglycan contents
were monitored by Hoechst 22358 assay and binding to DMMB,
respectively. Total RNA was extracted and reverse transcription was
carried out for cDNA ampliﬁcation via real-time RT-PCR. Ct values were
obtained for SOX9, ACAN, COL2A1, COL1A1, and COL10A1, using GAPDH
as a control for normalization, and fold inductions relative to luc-trea-
ted samples were measured using the 2-DDCt method. Each condition
was performed in duplicate in three experiments. The t-test was
employed with P  0.05 considered statistically signiﬁcant.
Results: Effective IGF-I expression was noted in rAAV-hIGF-I-treated
aspirates vis-a-vis control (rAAV-lacZ) condition. Enhanced chondro-
genic differentiation was observed in the aspirates after 21 days upon
IGF-I gene transfer versus lacZ as seen by a more robust toluidine blue
staining and stronger type-II collagen immunoreactivity. The candidate
IGF-I treatment also signiﬁcantly increased the DNA and proteoglycan
contents in the aspirates. These ﬁndings were corroborated at the gene
expression level by a real-time RT-PCR analysis of SOX9, ACAN, and
COL2A1. Of further note, IGF-I gene transfer also increased the expres-
sion of hypertrophic markers (COL1A1, COL10A1).
Conclusions: rAAV vectors can successfully modify human osteo-
arthritic bone marrow aspirates to overexpress IGF-I, leading to
enhanced metabolic and chondrogenic differentiation activities relative
to control treatment. Regulating IGF-I productionwill be necessary for a
tight control of terminal differentiation and hypertrophy before
adapting the present strategy to treat damaged articular cartilage.
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MICROARRAY COMPARISON BETWEEN HUMAN POLYDACTYLY
CHONDROCYTES AND ADULT KNEE CHONDROCYTES
E. Toyoda y, M. Sato y, T. Ukai y, T. Takahashi y, S. Nakamura z,
R. Matoba z, H. Akutsu x, A. Umezawa x, J. Mochida y. y Tokai Univ., Sch. of
Med., Kanagawa, Japan; zDNA Chip Res. Inc., Kanagawa, Japan; xNatl. Ctr.
for Child Hlth.and Dev., Tokyo, Japan
Purpose: To achieve our goal of treating osteoarthritis (OA) in the knee
through the use of chondrocyte sheets, we have conducted a clinical
study in which autologous chondrocyte sheets are transplanted to the
patient’s knee cartilaginous defect. From November of 2011, eight
patients with OA in the knee received autologous transplantation of
chondrocyte sheets, and as of November of 2014, successful regener-
ation of articular cartilage has been veriﬁed in all cases without any
serious adverse events. Nevertheless, this treatment method of autol-
ogous transplantation requires two surgeries for both harvesting and
transplantation, and limitations on the quantity and quality of cell
